The Platform of Plasma Users (PLUS) has released a statement regarding Plasma-Derived Medical Products (PDMPs) based on discussion at this year’s Stakeholder Consensus Conference. This statement highlights the importance of safe and effective PDMPs, such as immunoglobulin therapies, and emphasizes the role of manufacturers and regulatory agencies in guarenteeing safety and efficacy of all PDMPs.
Read the full statement here.
ImmUnity Canada is a national charity with five provincial chapters across the country.
We empower Canadians impacted by immunodeficiency disorders to live well through education, support, advocacy, community-building, and research.
Read the latest news and updates from ImmUnity Canada.
In support of the National Strategy for Drugs for Rare Diseases, the Canadian Drug Agency's (CDA) Newborn Screening Advisory Panel, which includes ImmUnity...
We're excited to introduce the two new members of the ImmUnity Canada Board of Directors. Stephanie and Sanjay both have personal connection to the PI...
In a project lead by Dr. Kantipuly, musically produced by Dr. Frishkopf, lyrics written by ImmUnity Canada Board Memeber Andrea, and sang by Dr. Olga...